| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CNMD | Common Stock | Sale | -$274K | -2.03K | -13.14% | $135.09 | 13.4K | Feb 2, 2022 | Direct | F1 |
| transaction | CNMD | Common Stock | Sale | -$575K | -4.2K | -31.34% | $136.96 | 9.2K | Feb 2, 2022 | Direct | F2 |
| transaction | CNMD | Common Stock | Sale | -$27.6K | -200 | -2.17% | $137.91 | 9K | Feb 2, 2022 | Direct | F3 |
| transaction | CNMD | Common Stock | Options Exercise | $176K | +2.55K | +28.32% | $69.03 | 11.5K | Feb 2, 2022 | Direct | |
| transaction | CNMD | Common Stock | Sale | -$344K | -2.55K | -22.07% | $135.08 | 9K | Feb 2, 2022 | Direct | F4 |
| transaction | CNMD | Common Stock | Options Exercise | $173K | +2.17K | +24.06% | $79.94 | 11.2K | Feb 2, 2022 | Direct | |
| transaction | CNMD | Common Stock | Sale | -$292K | -2.17K | -19.39% | $135.08 | 9K | Feb 2, 2022 | Direct | F5 |
| transaction | CNMD | Common Stock | Options Exercise | $136K | +1.84K | +20.48% | $73.94 | 10.8K | Feb 2, 2022 | Direct | |
| transaction | CNMD | Common Stock | Sale | -$249K | -1.84K | -17% | $135.06 | 9K | Feb 2, 2022 | Direct | F6 |
| transaction | CNMD | Common Stock | Options Exercise | $33.4K | +1K | +11.11% | $33.43 | 10K | Feb 2, 2022 | Direct | |
| transaction | CNMD | Common Stock | Tax liability | -$33.5K | -241 | -2.41% | $139.03 | 9.76K | Feb 2, 2022 | Direct | |
| transaction | CNMD | Common Stock | Options Exercise | $39.6K | +1K | +10.25% | $39.64 | 10.8K | Feb 2, 2022 | Direct | |
| transaction | CNMD | Common Stock | Tax liability | -$39.8K | -286 | -2.66% | $139.03 | 10.5K | Feb 2, 2022 | Direct | |
| transaction | CNMD | Common Stock | Options Exercise | $55.7K | +1K | +9.55% | $55.70 | 11.5K | Feb 2, 2022 | Direct | |
| transaction | CNMD | Common Stock | Tax liability | -$55.8K | -401 | -3.5% | $139.03 | 11.1K | Feb 2, 2022 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CNMD | Options To Purchase Common Stock | Options Exercise | $0 | -2.55K | -100% | $0.00* | 0 | Feb 2, 2022 | Common Stock | 2.55K | $69.03 | Direct | F7 |
| transaction | CNMD | Options To Purchase Common Stock | Options Exercise | $0 | -2.17K | -100% | $0.00* | 0 | Feb 2, 2022 | Common Stock | 2.17K | $79.94 | Direct | F7 |
| transaction | CNMD | Options To Purchase Common Stock | Options Exercise | $0 | -1.84K | -100% | $0.00* | 0 | Feb 2, 2022 | Common Stock | 1.84K | $73.94 | Direct | F8 |
| transaction | CNMD | Sars (Stock Appreciation Rights) | Options Exercise | $0 | -1K | -100% | $0.00* | 0 | Feb 2, 2022 | Common Stock | 1K | $33.43 | Direct | F9 |
| transaction | CNMD | Sars (Stock Appreciation Rights) | Options Exercise | $0 | -1K | -100% | $0.00* | 0 | Feb 2, 2022 | Common Stock | 1K | $39.64 | Direct | F10 |
| transaction | CNMD | Sars (Stock Appreciation Rights) | Options Exercise | $0 | -1K | -100% | $0.00* | 0 | Feb 2, 2022 | Common Stock | 1K | $55.70 | Direct |
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.00 to $135.83. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $136.29 to $137.06. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $137.88 to $137.94. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| F4 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.00 to $135.82. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| F5 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.00 to $135.84. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| F6 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.00 to $135.12. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| F7 | The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. |
| F8 | The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. |
| F9 | The stock appreciation rights ("SARs") were granted under the Company's 2007 Amended and Restated Non-Employee Director Equity Compensation Plan, with the SARs generally vesting 100% after a one year period. |
| F10 | The stock appreciation rights ("SARs") were granted under the Company's 2007 Amended and Restated Non-Employee Director Equity Compensation Plan, with the SARs generally vesting upon completion of the term of service. |